Detection of Acute Changes in Circulating Troponin in the Setting of Transient Stress Test-induced Myocardial Ischaemia Using an Ultrasensitive Assay: Results from TIMI 35
Overview
Affiliations
Aims: To determine whether an ultrasensitive assay can permit quantification of changes in circulating cardiac troponin (Tn) in the setting of stress test-induced myocardial ischaemia.
Methods And Results: Blood samples were obtained before, immediately after, and 2 and 4 h after stress testing with nuclear perfusion imaging in 120 patients. Troponin was measured using commercial assays as well as with a novel, ultrasensitive cardiac TnI assay with a limit of detection of 0.2 pg/mL. Using the ultrasensitive assay, TnI was detectable in all patients before stress testing (median 4.4 pg/mL, interquartile range 3.1-8.6 pg/mL). By 4 h, troponin levels were unchanged in patients without ischaemia, whereas circulating levels had increased by a median of 1.4 pg/mL (24% increase) in patients with mild ischaemia (P = 0.002) and by 2.1 pg/mL (40% increase) in patients with moderate-to-severe ischaemia (P = 0.0006). In contrast, changes in troponin levels across patients in different ischaemic categories were indistinguishable using commercial troponin assays. When added to clinical factors, a >1.3 pg/mL increase in TnI using the ultrasensitive assay was an independent predictor of ischaemia (odds ratio 3.54, P = 0.007).
Conclusion: Transient stress test-induced myocardial ischaemia is associated with a quantifiable increase in circulating troponin that is detectable with a novel, ultrasensitive TnI assay.
Carrasquer A, Cediel G, Gomez-Sanz A, Peiro O, Fort-Gallifa I, Bardaji A Front Cardiovasc Med. 2025; 11:1450619.
PMID: 39872884 PMC: 11769976. DOI: 10.3389/fcvm.2024.1450619.
Type 2 myocardial infarction: challenges in diagnosis and treatment.
Chapman A, Taggart C, Boeddinghaus J, Mills N, Fox K Eur Heart J. 2024; 46(6):504-517.
PMID: 39658094 PMC: 11804249. DOI: 10.1093/eurheartj/ehae803.
Circulating Progenitor Cells and Coronary Collaterals in Chronic Total Occlusion.
Gold D, Sandesara P, Kindya B, Gold M, Jain V, Vatsa N Int J Cardiol. 2024; 407:132104.
PMID: 38677332 PMC: 11559591. DOI: 10.1016/j.ijcard.2024.132104.
High Sensitivity Troponin Level and Benefits of Chronic Total Occlusion Revascularization.
Gold D, Sandesara P, Jain V, Gold M, Vatsa N, Desai S J Am Heart Assoc. 2023; 12(21):e031431.
PMID: 37929763 PMC: 10727412. DOI: 10.1161/JAHA.123.031431.
Giers J, Bartel A, Kirsch K, Muller S, Horstmann S, Gehlen H Animals (Basel). 2023; 13(19).
PMID: 37835716 PMC: 10572052. DOI: 10.3390/ani13193110.